CIK 0001621227
- Non-accelerated filer
- Smaller reporting company
Adaptimmune Therapeutics PLC
Sign in to watch- Ticker
- ADAPY
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- Operating
- Phone
- +44 1235430000
- Business address
- 60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
- Former names
- Adaptimmune Ltd
- 4 Open-market sale President, R&D sold 11,043 shares at $2.06 ($22,749)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Option exercise Chief Executive Officer acquired 1,773,100 shares (option exercise)
- 4 Open-market sale Chief Technology Officer sold 1,514 shares at $5.37 ($8,129)
- 4 Open-market sale Chief Operating Officer sold 2,271 shares at $5.37 ($12,194)
- 4 Open-market sale President, R & D sold 3,028 shares at $5.37 ($16,259)
- 4 Open-market sale Chief Financial Officer sold 3,084 shares at $5.37 ($16,559)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 11 of 18 · 351 filings